New GLP-1 for Alcohol Addiction and IBS, Instagram's AI Fake Crackdown + 5 New Health Tools - 1329

From The Chalene Show | Diet, Fitness & Life Balance Chalene Johnson

Eli Lilly is testing a new GLP-1 called brenipatide in phase three trials, and weight loss isn't even the main focus, researchers are watching it for alcohol use disorder, opioid addiction, bipolar disorder, and IBS. Chalene Johnson also breaks down a new Yale University study on why the hunger hormones ghrelin and leptin roar back the moment someone stops taking a GLP-1.

Then Chalene calls out an Instagram account called Baddie Bethany (also posting as Baddie Betty on Facebook), nearly a million followers and Instagram is rolling out a brand new AI content label. She also flags an AI "Dr. Chen" wellness account blending real health facts with false ones to earn trust.

Plus, five new health devices she's watching, including a toilet sensor called Throne, an AI skin scanner called SkinBit, and a caregiving wearable from the founders of Fitbit.

Topics discussed: Eli Lilly, brenipatide, Zepbound, Yale University, ghrelin, leptin, berberine, Baddie Bethany, Baddie Betty, Dr. Chen, Chen Family Wellness, Carrie Sisson, Instagram, Throne, SkinBit, Prenuvo, 3D Radiology, Eight Sleep, Apple, Fitbit, Lufu, Lindsey Clancy trial.

Join Chalene on Patreon her private podcast to hear all the latest on the Penthouse Drama and the Session with a Renowned Pet Psychic 👉chalene.com/more

Book your virtual visit today with MIDI! 👉chalene.com/test

🚨Questions Chalene Wants Your Thoughts on:

Would a GLP-1 built for addiction, not weight, help you?
Do you want a button that filters AI content out?
What is something you do today that AI will likely be doing for you in five years?